Evidence-Based Diabetes Management
September 2019
Volume: 25
Issue: 10
June 2019
Volume: 25
Issue: 7
March 2019
Volume: 25
Issue: 4
Advertisement
Advertisement
Trending on AJMC
1
Medicare Part D Ruxolitinib Spending Hits $49.6 Million as Use Surges
2
Peptide Regulation Debate Intensifies After FDA Advisory Panel's Controversial Vote
3
Surrogate End Points, Drug Costs Complicate Oncology Formularies
4
Perceptions About CGMs Among Primary Care Physicians and Endocrinologists
5